DERM (Journey Medical) Short Ratio


DERM Journey Medical Corp DERM
62 GF Score
Price $7.09
GF Value $4.19
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Journey Medical Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

DERM
62GF Score
Journey Medical Corp DERM
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Journey Medical (DERM) Overvalued in 2026?

Based on GuruFocus' analysis, Journey Medical stock appears to be overvalued. The current stock price of $7.09 is trading 69.1% above its estimated GF Value™ of $4.19. GuruFocus considers Journey Medical to be Significantly Overvalued.

Key valuation signals for DERM:

  • Short Ratio:
  • GF Value™: $4.19 vs. price of $7.09 (69.1% above fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the DERM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Journey Medical Business Description

Address 9237 E Via de Ventura Boulevard, Suite 105, Scottsdale, AZ, USA, 85258
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
62GF Score

Get the complete analysis for DERM

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.09
Price
$4.19
GF Value